BSE Live
Mar 23, 16:01Prev. Close
11.80
Open Price
11.73
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 23, 15:48Prev. Close
11.78
Open Price
11.76
Bid Price (Qty.)
11.19 (1699)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Syncom Formulations (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 12.41 | 6.23 | 6.23 | 5.92 | 5.62 | |
| Total Share Capital | 12.41 | 6.23 | 6.23 | 5.92 | 5.62 | |
| Reserves and Surplus | 42.64 | 34.76 | 32.66 | 28.32 | 23.64 | |
| Total Reserves and Surplus | 42.64 | 34.76 | 32.66 | 28.32 | 23.64 | |
| Total Shareholders Funds | 55.05 | 40.98 | 38.88 | 34.24 | 29.26 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 7.20 | 8.94 | 5.86 | 4.32 | 5.60 | |
| Deferred Tax Liabilities [Net] | 4.74 | 4.59 | 4.22 | 3.68 | 3.58 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 11.94 | 13.53 | 10.08 | 8.00 | 9.18 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 2.09 | 1.80 | 1.37 | 2.72 | 0.56 | |
| Trade Payables | 16.09 | 2.60 | 13.49 | 4.50 | 3.85 | |
| Other Current Liabilities | 3.68 | 2.19 | 2.16 | 1.79 | 1.03 | |
| Short Term Provisions | 3.46 | 2.05 | 1.86 | 2.69 | 3.42 | |
| Total Current Liabilities | 25.33 | 8.64 | 18.87 | 11.70 | 8.87 | |
| Total Capital And Liabilities | 92.32 | 63.31 | 67.98 | 53.94 | 47.31 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 31.58 | 32.31 | 31.43 | 25.41 | 19.02 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.04 | 0.03 | 0.26 | 0.69 | 2.31 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 31.63 | 32.34 | 31.69 | 26.10 | 21.33 | |
| Non-Current Investments | 0.04 | 0.04 | 0.04 | 0.04 | 0.42 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.29 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.21 | 0.07 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 31.88 | 32.45 | 31.73 | 26.14 | 22.03 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 7.74 | 2.75 | 5.56 | 3.42 | 6.18 | |
| Trade Receivables | 23.23 | 12.87 | 17.80 | 14.44 | 12.59 | |
| Cash And Cash Equivalents | 9.18 | 2.59 | 2.48 | 2.23 | 0.79 | |
| Short Term Loans And Advances | 20.29 | 12.65 | 10.42 | 7.71 | 5.72 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 60.44 | 30.85 | 36.26 | 27.80 | 25.27 | |
| Total Assets | 92.32 | 63.31 | 67.98 | 53.94 | 47.31 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.79 | 1.25 | 1.13 | 0.86 | 4.77 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 1.24 | 4.01 | 3.74 | 3.15 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.12 | 0.17 | 0.02 | 0.01 | 0.11 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 66.63 | 46.15 | 54.80 | 48.43 | 41.13 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | 0.25 | |
| Non-Current Investments Unquoted Book Value | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
26.11.2025
Syncom Formula Consolidated September 2025 Net Sales at Rs 121.72 crore, up 18.96% Y-o-Y
24.11.2025
Syncom Formula Standalone September 2025 Net Sales at Rs 121.44 crore, up 19.65% Y-o-Y
22.08.2025
Syncom Formula Standalone June 2025 Net Sales at Rs 116.55 crore, up 34.22% Y-o-Y
20.05.2025
Syncom Formula Consolidated March 2025 Net Sales at Rs 148.88 crore, up 99.64% Y-o-Y
26.11.2025
Syncom Formula Consolidated September 2025 Net Sales at Rs 121.72 crore, up 18.96% Y-o-Y
24.11.2025
Syncom Formula Standalone September 2025 Net Sales at Rs 121.44 crore, up 19.65% Y-o-Y
22.08.2025
Syncom Formula Standalone June 2025 Net Sales at Rs 116.55 crore, up 34.22% Y-o-Y
20.05.2025
Syncom Formula Consolidated March 2025 Net Sales at Rs 148.88 crore, up 99.64% Y-o-Y
23.03.2026
Alkem Laboratories gets DCGI nod for Semaglutide Injection; share price fall marginally
23.03.2026
22.03.2026
Sell-on-rise market? SBI Securities sees Nifty under pressure, picks two stocks for the week ahead
20.03.2026
Eris Lifesciences, Natco Pharma to launch generic Ozempic at 90% cheaper price
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth